Johnson & Johnson
Update in progressJNJ (NYSE)
- Company RatingAt RiskCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - General
Johnson & Johnson and its subsidiaries develop, manufacture, and sell healthcare products worldwide in two segments: Innovative Medicine and MedTech. Innovative Medicine provides prescription therapies across oncology, immunology, neuroscience, infectious diseases, and cardiovascular/metabolic areas, distributed through hospitals, retailers, wholesalers, and clinicians. MedTech offers surgical, orthopedic, cardiovascular, and vision devices, robotics, implants, and eye care products.
Company score
- Sentiment
- -2.00
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -1.27
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -2.88
- Governance
- -3.42
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -2.02
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -2.01
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE (NYQ)
- LocationUnited States
- CEOMr. Joaquin Duato
- Founded1886
- Employees138,200
- Websitewww.jnj.com
Identifiers
- ISINUS4781601046
- FIGIBBG000BMHYD1
- LEI549300G0CFPGEF6X2043
- CUSIP478160104
- CIK0000200406